From €1481EUR$1,500USD£1,233GBP
- Report
- May 2023
- 80 Pages
South Korea
From €1481EUR$1,500USD£1,233GBP
- Report
- May 2023
- 80 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- May 2023
- 80 Pages
India
From €1481EUR$1,500USD£1,233GBP
- Report
- May 2023
- 80 Pages
Germany
From €1481EUR$1,500USD£1,233GBP
- Report
- May 2023
- 350 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- October 2021
- 40 Pages
India
From €1481EUR$1,500USD£1,233GBP
- Report
- October 2021
- 40 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- October 2021
- 40 Pages
United States
From €1481EUR$1,500USD£1,233GBP
- Report
- October 2021
- 100 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- August 2021
- 40 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Training
- July 2023
- 2 Days
Global
From €1573EUR$1,593USD£1,309GBP
- Webinar
- February 2023
- 60 Minutes
Global
From €351EUR$355USD£292GBP
- Training
- July 2024
- 3 Hours
Global
From €483EUR$490USD£402GBP
- Training
- September 2023
- 3 Hours
Global
From €1577EUR$1,597USD£1,312GBP
- Webinar
- December 2022
- 120 Minutes
Global
From €483EUR$490USD£402GBP
- Training
- January 2022
- 2 Days
Global
From €1974EUR$1,999USD£1,643GBP
- Training
- 90 Minutes
Global
- Training
- November 2024
- 3 Hours
Global
From €605EUR$613USD£504GBP
- Report
- October 2024
Italy
From €1827EUR$1,850USD£1,520GBP
The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more